THURSDAY, Oct. 10, 2024b (HealthDay News) — There’s a small but significant increased of certain cancers in people battling multiple sclerosis (MS), new research shows. Those malignancies include cancers of the bladder, brain and cervix, said a team from Rennes University in France. “People with MS undergo an increased numberContinue Reading

TUESDAY, Oct. 8, 2024 (HealthDay News) — A recently approved targeted chemotherapy drug can significantly extend the lives of advanced breast cancer patients who have developed tumors in their brains, new clinical trial results show. On average, patients receiving the drug Enhertu (trastuzumab deruxtecan) survived more than 17 months withoutContinue Reading